Publication:
Isolated abducens nerve palsy induced by vincristine therapy

dc.contributor.authorsToker, Ebru; Yenice, Ozlem; Oğüt, Mehdi Süha
dc.date.accessioned2022-03-15T11:11:15Z
dc.date.accessioned2026-01-11T09:03:32Z
dc.date.available2022-03-15T11:11:15Z
dc.date.issued2004
dc.description.abstractWe report a 28-year-old man with non-Hodgkin's lymphoma who presented with acute onset of diplopia 3 weeks after the completion of combination chemotherapy with vincristine. He had a left esotropia with marked decrease in abduction. Magnetic resonance imaging scan of the brain showed thickening and enhancement of the left abducens nerve. Lymphomatous and other intracranial pathologies were excluded, and vincristine neurotoxicity was considered as the possible etiology of the abducens nerve palsy. His diplopia improved gradually, then completely resolved 4 weeks after the cessation of vincristine therapy. We concluded that isolated ocular muscle paresis can be the presenting sing of a toxic neuropathy associated with vincristine use.
dc.identifier.doi10.1016/S1091853103003239
dc.identifier.issn1091-8531
dc.identifier.pubmedPMID: 14970804
dc.identifier.urihttps://hdl.handle.net/11424/248877
dc.language.isoeng
dc.relation.ispartofJournal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAdult
dc.subjectHumans
dc.subjectTreatment Outcome
dc.subjectMale
dc.subjectVisual Acuity
dc.subjectMagnetic Resonance Imaging
dc.subjectDiplopia
dc.subjectAntineoplastic Agents, Phytogenic
dc.subjectLymphoma, Non-Hodgkin
dc.subjectAbducens Nerve
dc.subjectAbducens Nerve Diseases
dc.subjectVincristine
dc.titleIsolated abducens nerve palsy induced by vincristine therapy
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage71
oaire.citation.startPage69
oaire.citation.titleJournal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus
oaire.citation.volume1

Files